The efficacy and safety of monoclonal antibody therapies for interstitial cystitis/bladder pain syndrome: A meta-analysis of randomized controlled trials.

MLA

Cao, Zhi-Gang, et al. “The Efficacy and Safety of Monoclonal Antibody Therapies for Interstitial Cystitis/Bladder Pain Syndrome: A Meta-Analysis of Randomized Controlled Trials.” Neurourology and Urodynamics, vol. 43, no. 8, Nov. 2024, pp. 1903–09. EBSCOhost, https://doi.org/10.1002/nau.25547.

APA

Cao, Z.-G., Li, F.-D., Zhang, C.-L., Luo, G.-X., & Chang, D.-H. (2024). The efficacy and safety of monoclonal antibody therapies for interstitial cystitis/bladder pain syndrome: A meta-analysis of randomized controlled trials. Neurourology and Urodynamics, 43(8), 1903–1909. https://doi.org/10.1002/nau.25547

Chicago

Cao, Zhi-Gang, Fu-Dong Li, Chun-Lei Zhang, Guo-Xiong Luo, and De-Hui Chang. 2024. “The Efficacy and Safety of Monoclonal Antibody Therapies for Interstitial Cystitis/Bladder Pain Syndrome: A Meta-Analysis of Randomized Controlled Trials.” Neurourology and Urodynamics 43 (8): 1903–9. doi:10.1002/nau.25547.